Insurance

Patrick J. Gallagher’s $79.59 share purchase of AJG at a deep discount signals strong insider confidence, hinting at a potential rebound and higher shareholder value.

Insider sale of 3,900 Root Inc‑OH shares at $47.88 shows routine plan execution amid market decline—analyze the impact on long‑term value and investor confidence.

Globe Life insider trades reveal routine liquidity moves by CEO Darden James Matthew that spark short‑term volatility yet leave core fundamentals intact—an essential read for investors and governance analysts alike.

Insightful analysis of James River Group Holdings’ insider trades, revealing executive confidence, valuation gaps, and strategic growth cues for investors.

Marsh & McLennan insider trading: executives buy & sell at market price, keeping long‑term stakes amid a 21% YTD decline—watch liquidity‑managed moves, not hidden signals.

Oscar Health insiders buying shares amid cautious cash strategy: CEO and execs’ RSU purchases and sales reveal confidence in long‑term tech‑driven growth and future upside.

AIIG insider buying reveals confidence in specialty‑property growth, digital underwriting & climate risk plans—yet regulatory capital hikes & hurricane exposure could hit profits.

MetLife insider sales reveal leadership uncertainty—over 40,000 shares dumped in one day—raising questions about future strategy, earnings, and market sentiment.

Insider buys 2026 options & RSUs at Old Republic—CEO, CFO, SVPs all backing dividend growth, signaling long‑term confidence and a stable price trajectory.

Insider buying by Skyward’s top execs signals confidence—why this uptick matters for investors and how it could impact the company’s premium growth and parametric strategy.